<SEC-DOCUMENT>0001079973-19-000116-index.html : 20190607
<SEC-HEADER>0001079973-19-000116.hdr.sgml : 20190607

<ACCEPTANCE-DATETIME>20190306172738

<PRIVATE-TO-PUBLIC>

ACCESSION NUMBER:		0001079973-19-000116

CONFORMED SUBMISSION TYPE:	10-Q/A

PUBLIC DOCUMENT COUNT:		5

CONFORMED PERIOD OF REPORT:	20180930

FILED AS OF DATE:		20190306

DATE AS OF CHANGE:		20190306


FILER:


	COMPANY DATA:	

		COMPANY CONFORMED NAME:			Riot Blockchain, Inc.

		CENTRAL INDEX KEY:			0001167419

		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]

		IRS NUMBER:				841553387

		STATE OF INCORPORATION:			NV

		FISCAL YEAR END:			1231



	FILING VALUES:

		FORM TYPE:		10-Q/A

		SEC ACT:		1934 Act

		SEC FILE NUMBER:	001-33675

		FILM NUMBER:		19663536



	BUSINESS ADDRESS:	

		STREET 1:		202 6TH STREET, SUITE 401

		CITY:			CASTLE ROCK

		STATE:			CO

		ZIP:			80104

		BUSINESS PHONE:		303-794-2000



	MAIL ADDRESS:	

		STREET 1:		202 6TH STREET, SUITE 401

		CITY:			CASTLE ROCK

		STATE:			CO

		ZIP:			80104



	FORMER COMPANY:	

		FORMER CONFORMED NAME:	Bioptix, Inc.

		DATE OF NAME CHANGE:	20161201



	FORMER COMPANY:	

		FORMER CONFORMED NAME:	Venaxis, Inc.

		DATE OF NAME CHANGE:	20121218



	FORMER COMPANY:	

		FORMER CONFORMED NAME:	AspenBio Pharma, Inc.

		DATE OF NAME CHANGE:	20051110



</SEC-HEADER>

<DOCUMENT>
<TYPE>10-Q/A
<SEQUENCE>1
<FILENAME>riot_10qa2-093018.htm
<DESCRIPTION>FORM 10-Q AMENDMENT NO 2
<TEXT>
Document 1 - file: riot_10qa2-093018.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>2
<FILENAME>ex31x1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
Document 2 - file: ex31x1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>ex31x2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
Document 3 - file: ex31x2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>4
<FILENAME>ex32.htm
<DESCRIPTION>EXHIBIT 32
<TEXT>
Document 4 - file: ex32.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>COVER
<SEQUENCE>5
<FILENAME>filename5.htm
<TEXT>
Document 5 - file: filename5.htm

</DOCUMENT>
</SEC-DOCUMENT>